Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Sovremennaya Revmatologiya is Scopus-indexed (Q4, CiteScore 0.8), DOAJ. Published by Ima-Press Publishing House.
Checked against the index lists dated .
ISSN 1996-7012Verify ISSN ↗2310-158XVerify ISSN ↗
Publisher: Ima-Press Publishing House
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 232 / 278 | 16th | Q4 |
| Rheumatology | 67 / 77 | 13th | Q4 |
| Immunology and Allergy | 205 / 234 | 12th | Q4 |
| Immunology | 224 / 243 | 8th | Q4 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q4, CiteScore 0.8.
Sovremennaya Revmatologiya is Q4 in Pharmacology (medical) (rank 232 of 278), Q4 in Rheumatology (rank 67 of 77) and Q4 in Immunology and Allergy (rank 205 of 234), by CiteScore 2025. It is ranked in 4 subject areas in all.
Sovremennaya Revmatologiya is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.8, quartile Q4, 16th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.134, quartile Q4, with an H-index of 12.
Sovremennaya Revmatologiya is published by Ima-Press Publishing House. Its print ISSN is 1996-7012 and its online ISSN is 2310-158X.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Sovremennaya Revmatologiya has an h-index of 17 and a 2-year mean of 0.68 citations per paper (OpenAlex). Its Scopus CiteScore is 0.8, quartile Q4. On 2-year citations it ranks #209 of 271 Scopus journals in Pharmacology (medical).
Sovremennaya Revmatologiya published 101 papers in 2025; its busiest recent year was 2021 with 116. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from Russia (96.5%), Kyrgyzstan (3%) and Kazakhstan (0.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.